Evoke Pharma Inc. sell StockNews.com
Start price
16.02.25
/
50%
€0.37
Target price
16.02.26
-
Performance (%)
-
End price
17.02.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Evoke Pharma Inc. | - | - | - |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by StockNews_com for this prediction
In the thread Evoke Pharma Inc. diskutieren
Evoke Pharma, Inc. (NASDAQ: EVOK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for EVOK provided by MarketBeat
In the thread Trading Evoke Pharma Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten